The global Alzheimer’s drugs market is going to grow at a CAGR of 1.90% during the period 2017-2021 with Key vendors being Allergan, Eisai Pharmaceuticals, Johnson & Johnson, and Novartis, with other prominent vendors Amgen and Pfizer. Much of the increase will be in developing countries. Already 58% of people with dementia live in low and middle income countries, but by 2050 this will rise to 68%.

Read Pharmana Wider View: Vol1.Dementia to get insights

Topics in this newsletter: